The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression
AUTOR(ES)
Grossmann, Mathis
FONTE
Oxford University Press
RESUMO
Rel and RelA, individually dispensable for lymphopoiesis, serve unique functions in activated B and T cells. Here their combined roles in lymphocyte development were examined in chimeric mice repopulated with c-rel–/– rela–/– fetal liver hemopoietic stem cells. Mice engrafted with double-mutant cells lacked mature IgMloIgDhi B cells, and numbers of peripheral CD4+ and CD8+ T cells were markedly reduced. The absence of mature B cells was associated with impaired survival that coincided with reduced expression of bcl-2 and A1. bcl-2 transgene expression not only prevented apoptosis and increased peripheral B-cell numbers, but also induced further maturation to an IgMloIgDhi phenotype. In contrast, the survival of double-mutant T cells was normal and the bcl-2 transgene could not rectify the peripheral T-cell deficit. These findings indicate that Rel and RelA serve essential, albeit redundant, functions during the later antigen-independent stages of B- and T-cell maturation, with these transcription factors promoting the survival of peripheral B cells in part by upregulating Bcl-2.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=305873Documentos Relacionados
- Buffy, a Drosophila Bcl-2 protein, has anti-apoptotic and cell cycle inhibitory functions
- Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members
- Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.
- Transformation of Bone Marrow B-Cell Progenitors by E2A-HLF Requires Coexpression of BCL-2
- Human RIF1 encodes an anti-apoptotic factor required for DNA repair